Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.
Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius ...
The primary endpoint for the study is evaluating ... therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). With successful completion of the second Phase ...
Verywell Health on MSN1y
What Cancer Can Cause Itchy Skin?
Medically reviewed by Oliver Eng, MD Itchy skin, or pruritus, can be a symptom of some cancers, including blood-related, skin, liver, gallbladder, and bile-duct cancer cancers. However, other causes ...